PepGen Inc (PEPG)
13.09
-0.56
(-4.10%)
USD |
NASDAQ |
May 20, 13:25
PepGen Shareholders Equity (Quarterly): 179.00M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 179.00M |
| December 31, 2023 | 108.42M |
| September 30, 2023 | 125.86M |
| June 30, 2023 | 147.28M |
| March 31, 2023 | 164.84M |
| Date | Value |
|---|---|
| December 31, 2022 | 179.63M |
| September 30, 2022 | 192.94M |
| June 30, 2022 | 210.22M |
| March 31, 2022 | 115.59M |
| December 31, 2021 | 133.09M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
108.42M
Minimum
Dec 2023
210.22M
Maximum
Jun 2022
155.69M
Average
156.06M
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 561.41M |
| Vertex Pharmaceuticals Inc | 18.55B |
| Sarepta Therapeutics Inc | 961.19M |
| PTC Therapeutics Inc | -893.92M |
| Regenxbio Inc | 390.67M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 207.00M |
| Total Liabilities (Quarterly) | 28.00M |